lenalidomide
Commercial- Indications
- Cancer
Company intelligence / Profile preview
Lotus Pharmaceutical operates a best-in-class R&D and manufacturing platform with a focus on high-value, difficult-to-make generic pharmaceuticals. The company has over 250 products marketed globally and more than 100 projects in development or registration. Its main therapeutic areas are oncology, CNS, cardiovascular, women’s health, and anti-obesity. It leverages partnerships for global reach and was acquired by Alvogen in 2014.
4 more assets in the full pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lotus Pharmaceutical.